International Federation for the Surgery and Other Therapies for Obesity (IFSO) global consensus recommendations for optimizing outcomes after sleeve gastrectomy

By
Ricardo V Cohen
Mohammad Kermansaravi
Randy Levinson
Muffazal Lakdawala
Chetan Parmar
Yosuke Seki
Gerhard Prager
Paulina Salminen
members of the Global Consensus Recommendations for Optimizing Outcomes after Sleeve Gastrectomy
M Ackerman
N Alfaris
A Aly
A Aminian
S Aparicio
J Ard
C Boza
W Brown
B A Dayyeh
C Domene
M Felsenreich
K Gawdat
A Haddad
M Herrera
K Higa
K Kasama
L Kow
W J Lee
N D Lorenzo
S Mattar
A Miras
V Moize
A Nimeri
C Peng
A S Pernaute
R Peterli
T Petry
J Ponce
Y Preiss
N Reddy
R Rosenthal
S A Sabah
A Schroeder
A Shabbir
C Stier
October 15, 2025
0 min

1

Obesity is a global pandemic, with projections indicating 3.80 billion adults will be affected by overweight and obesity by 2050.
2

Sleeve gastrectomy (SG) is the most widely performed metabolic bariatric surgery but may lead to suboptimal postoperative outcomes.
3

De novo gastro-oesophageal reflux disease (GORD) occurs in a significant percentage of patients post-SG, with rates of 52% and 43% in two major trials.
4

The International Federation for the Surgery of Obesity and Metabolic Disorders developed guidelines to manage recurrent weight gain and GORD after SG.
5

A multidisciplinary panel of experts utilized a Delphi process to create evidence-based recommendations for managing unfavorable outcomes after SG.

1